Back to search

National and Kapodistrian University of Athens

Ο ρόλος της πρωτεΐνης S100B στον ορό αίματος σε ασθενείς με καταπληξία χωρίς εγκεφαλική βλάβη

Abstract

dc:description

Serum S100B protein is an acknowledged biomarker of brain injury. However, increased concentrations of S100B have been reported in hemorrhagic shock. Also, acute blood loss is associated with inflammatory response. The aim of this study was to investigate the concentrations of serum S100B and the potential relationships with interleukin (IL)-6, severity of tissue hypoperfusion and prognosis in patients admitted for surgical control of severe hemorrhage. Patients undergone elective abdominal aortic aneurysm surgery participated as controls. Serum samples were drawn after induction of anesthesia, at the end of surgery and after 6 and 24 hours. Sixty-four patients with severe hemorrhage (23 trauma and 41 nontrauma etiologies) and 17 controls were included. Increased preoperative concentrations of S100B protein (1.70 ± 2.13 and 0.81 ± 1.23 µg/l) and IL-6 (241 ± 291 and 226 ± 238 pg/ml) were found in patients with traumatic and non traumatic reason of severe hemorrhage, respectively, and remained elevated throughout 24 hours. Trauma patients exhibited higher preoperative S100B levels as compared to nontrauma (p<0.05). Overall mortality was 47%. In control patients both preoperative S100B and IL-6 levels were within normal limits and increased at the end of surgery (p< 0.001 and p< 0.01 respectively). Preoperative S100B correlated with IL-6 (r=0.78, p< 0.01), arterial lactate (r=0.50, p<0.01), pH (r=-0.45, p< 0.01), and bicarbonate (r= -0.40, p< 0.01). Multiple analysis revealed that preoperative S100B and lactate levels were independently associated with clinical outcome in trauma and nontrauma patients, respectively. Preoperative S100B value yielded receiver operator characteristics curve areas of 0.73 and 0.80 in predicting death for all patients and for the subgroup of trauma patients, respectively. These results indicate that severe hemorrhage in patients without brain injury is associated with increased serum levels of S100B, which correlate with IL-6 and tissue hypoperfusion indices. Moreover, the predictive ability of S100B for mortality, suggests that it could be a marker of potential clinical value in identifying, among patients with severe hemorrhage, those at greater risk for adverse outcome.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stathopoulos, Anastasios
  • Σταθόπουλος, Αναστάσιος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41189

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stathopoulos, Anastasios; Σταθόπουλος, Αναστάσιος. Ο ρόλος της πρωτεΐνης S100B στον ορό αίματος σε ασθενείς με καταπληξία χωρίς εγκεφαλική βλάβη. National and Kapodistrian University of Athens, 2013. http://hdl.handle.net/10442/hedi/41189